Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for ALK 1
Most Correlated Studies
- Lymph node biopsies of ALK-positive or negative anaplastic large cell lymphoma patients
- Anaplastic Large Cell Lymphoma and ALK-mediated signaling inhibition by RNAi and compounds
- Non-small cell lung cancer H3122 cells selected for resistance or sensitivity to crizotinib or X-376
- Pediatric neuroblastomas & primitive neuroectodermal tumors treated with decitabine & trichostatin A
- Lung adenocarcinomas with and without mutations in ALK, EGFR, KRAS
Most Relevant Literature
- Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 muta…
- Hereditary hemorrhagic telangiectasia: First demonstration of a founder effect in Italy; the ACVRL1 …
- Establishment of a human induced pluripotent stem cell line, KMUGMCi001-A, from a patient bearing a …
- Hsa_circ_0129047 regulates the miR-375/ACVRL1 axis to attenuate the progression of lung adenocarcino…
- Curaçao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a path…
Most Relevant Clinical Trials
- A Study of NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangemen…
- Phase 1 ALKS 1140 in Healthy Adults
- Phase 1 Safety Study of ALK-001 in Healthy Volunteers
- Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer
- Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung C…
